China's A-Shares Add $7 Trillion in Two Years — So Who Actually Won?

Two years ago this week, Chinese stocks staged one of the most dramatic turnarounds in their history. On September 24, 2024, the Shanghai Composite Index jumped 4.15% in a single session — its biggest one-day gain in four years — after touching a low near 2,689 points earlier that month. By September 24, 2026, the same index had climbed to about 3,888, a cumulative rise of roughly 45%. Add it all up, and the total market value of companies listed in Shanghai and Shenzhen grew by about 51 trillion yuan, according to Chinese financial data provider Gelonghui. That is trillions of dollars in newly created paper wealth.

So why does the mood among retail investors feel so muted? Ask a typical Chinese stock trader whether the past two years made them money, and the answer is often a shrug or a sigh. The reason lies in the shape of the rally. Gains have been concentrated in a relatively narrow set of sectors — semiconductors, artificial intelligence hardware, innovative drugmakers and defense-related manufacturers — while large parts of the market, especially older industrial and consumer names, have lagged badly.

Indexes measure the whole basket, but people buy individual stocks. An investor who held banks, property developers or traditional retailers through the period may have watched the headline number soar while their own account barely moved. Meanwhile, the sheer scale of the headline gain — 51 trillion yuan, comparable to the annual output of several large economies — can create a misleading impression that everyone shared in it.

The exchange is now trying to make that basket broader and easier to access. On September 29, the Shanghai Stock Exchange and its index subsidiary will launch two new benchmarks: a STAR Market innovative-pharma leaders index and a STAR Market software services index. The pharma gauge draws 40 companies from both the technology-focused STAR board and the main Shanghai board, weighted toward firms with strong research pipelines and growth potential. Such products give fund managers ready-made tools for exchange-traded funds, which in turn let ordinary savers buy a slice of a theme rather than betting on one company.

The two-year rally also reflects a broader shift in where Chinese household money is flowing. With deposit rates low and property no longer the default store of value, more savings have moved toward equities and bond funds. Money has also been crossing the border: on a single recent day, mainland investors bought a net 2.9 billion Hong Kong dollars of Hong Kong-listed shares, picking up names such as Tencent and materials maker Kingboard Laminates while trimming positions in biotech and chip stocks. That southbound flow has become a steady feature of the market.

None of this guarantees smooth sailing. On the very day the two-year milestone was marked, Chinese shares fell across the board, with the Shanghai Composite down 1.22% and the tech-heavy ChiNext off 2.68%. More than 4,300 individual stocks declined. Trading volume also shrank, a reminder that enthusiasm can cool quickly. Overseas, global bond markets were jittery, with Japanese 10-year yields hitting their highest level since 1996 — a reminder that China’s markets do not move in isolation.

For global readers, the takeaway is less about any single number than about structure. China’s equity market has become larger, more institutional and more thematic over two years, with new indexes designed to channel money into strategic industries like biotech and software. Whether that translates into broader household prosperity depends on something indexes cannot capture: how widely the gains are spread. Until then, the 51 trillion yuan question will keep echoing in trading halls across the country.